Facial plast Surg 2004; 20(2): 157-163
DOI: 10.1055/s-2004-861758
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Soft Tissue Augmentation Using Sculptra

Gail Humble1 , Douglas Mest1
  • 1Blue Pacific Aesthetic Medical Group, Hermosa Beach, CA
Further Information

Publication History

Publication Date:
11 January 2005 (online)


Sculptra (poly-L-lactic acid) as of August 2004 has been approved by the U.S. Food and Drug Administration as the first injectable facial volumizer in the treatment of lipoatrophy. Lipoatrophy is often seen in HIV-positive patients and is felt to be multifactorial. This article reviews European and U.S. clinical study data and summarize treatment technique for both on label and off-label use.